T80.5
Anaphylactic reaction due to serum
Clinical Classification Guidelines
Inclusion Terms
- Allergic shock due to serum
- Anaphylactic shock due to serum
- Anaphylactoid reaction due to serum
- Anaphylaxis due to serum
Excludes Type 1
- ABO incompatibility reaction due to transfusion of blood or blood products (T80.3-)
- allergic reaction or shock NOS (T78.2)
- anaphylactic reaction or shock NOS (T78.2)
- anaphylactic reaction or shock due to adverse effect of correct medicinal substance properly administered (T88.6)
- other serum reaction (T80.6-)
Medical Intelligence & Overview
Anaphylactic reaction due to serum, classified under ICD-10 code T80.5, is a severe allergic response triggered by exposure to serum-based medications or products. Serums are often used in medical treatments, vaccines, or diagnostic tests, but in some cases, they can provoke an intense immune system reaction. Recognizing the causes, symptoms, and potential diagnostic procedures helps in understanding this critical condition, although specific medical management should be sought through healthcare professionals.
Causes & Symptoms
Clinical Causes: Administration of serum-based medications, such as antivenoms or immunoglobulins Use of diagnostic or therapeutic serums containing proteins or other foreign substances Previous allergy or sensitivity to specific serum components Rapid infusion of serum without proper allergy assessments Cross-reactivity with other allergens leading to hypersensitivity reactions
Key Symptoms: Difficulty breathing or shortness of breath Swelling of the face, lips, tongue, or throat (angioedema) Hives or skin rash Low blood pressure (hypotension) Rapid or weak pulse Nausea, vomiting, or abdominal pain Feeling of dizziness or fainting Sense of impending doom or anxiety
Diagnostic & Treatment
Diagnosis Path: Diagnosing an anaphylactic reaction due to serum primarily involves clinical evaluation based on the presentation of symptoms shortly after serum exposure. Healthcare providers may review the patient's medical history and previous allergies. Laboratory tests, such as serum tryptase levels, can support diagnosis, especially in confirming mast cell activation. Allergy testing may be performed later to identify specific sensitivities and prevent future reactions.
Treatment Protocols: Immediate treatment of anaphylactic reactions includes the administration of epinephrine via intramuscular injection, which can rapidly reverse symptoms. Additional treatments may involve antihistamines to manage hives and rash, corticosteroids to reduce inflammation, and respiratory support in cases of significant breathing difficulty. Patients are often observed closely after initial treatment, and measures are taken to prevent recurrence, including discontinuing the suspected serum and providing allergy education. In some cases, allergy immunotherapy or desensitization procedures may be considered under medical supervision.
Clinical Advice & FAQs
Billing Guidance
Is T80.5 a billable ICD-10 code?
Yes, T80.5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T80.5?
Clinical documentation must specify the nature of Anaphylactic reaction due to serum and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
